Regulus Therapeutics Inc Lands $20,000,000 Series A Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c94f2ff1-bcdb-461f-af61-eb2255003d0d&Preview=1 - Date
3/4/2009 - Company Name
Regulus Therapeutics Inc - Mailing Address
1896 Rutherford Road Carlsbad, CA 92008-7208 - Company Description
Regulus Therapeutics, Inc., is a biopharmaceutical company created to discover, develop and commercialize microRNA-targeted therapeutics. microRNAs are small non-coding RNAs that regulate networks of genes and biological pathways through post-transcriptional mechanisms. microRNAs function by modulating levels of many target gene mRNAs and/or proteins. Modulation of mRNA targets by microRNAs finely tunes biological pathway activities and deregulated microRNA expression can profoundly affect disease pathways. - Website
http://www.regulusrx.com - Transaction Type
Venture Equity - Transaction Amount
$20,000,000 - Transaction Round
Series A - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
Alnylam Pharmaceuticals - Venture Investor
Isis Pharmaceuticals, Inc
